Does TRABECTEDIN Cause Infusion site extravasation? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Infusion site extravasation have been filed in association with TRABECTEDIN (YONDELIS). This represents 0.8% of all adverse event reports for TRABECTEDIN.
15
Reports of Infusion site extravasation with TRABECTEDIN
0.8%
of all TRABECTEDIN reports
0
Deaths
7
Hospitalizations
How Dangerous Is Infusion site extravasation From TRABECTEDIN?
Of the 15 reports, 7 (46.7%) required hospitalization.
Is Infusion site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRABECTEDIN. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TRABECTEDIN Cause?
Neutropenia (207)
Anaemia (189)
Thrombocytopenia (172)
Nausea (160)
Febrile neutropenia (142)
Pancytopenia (124)
Vomiting (121)
Rhabdomyolysis (117)
Off label use (105)
Alanine aminotransferase increased (104)
What Other Drugs Cause Infusion site extravasation?
HUMAN IMMUNOGLOBULIN G (822)
INFLIXIMAB (435)
INFLIXIMAB-DYYB (328)
TREPROSTINIL (256)
VEDOLIZUMAB (199)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (185)
REMDESIVIR (144)
FERRIC CARBOXYMALTOSE (118)
RITUXIMAB (82)
NATALIZUMAB (70)
Which TRABECTEDIN Alternatives Have Lower Infusion site extravasation Risk?
TRABECTEDIN vs TRACLEER
TRABECTEDIN vs TRADJENTA
TRABECTEDIN vs TRALOKINUMAB-LDRM
TRABECTEDIN vs TRAMADOL
TRABECTEDIN vs TRAMADOL\TRAMADOL